Cited In for PMID: 39921267

Your saved search

Your RSS Feed

Page 1

Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database.

Kwon J, Thiara D, Watanabe JH. Kwon J, et al. Expert Rev Endocrinol Metab. 2025 Mar;20(2):163-168. doi: 10.1080/17446651.2025.2462100. Epub 2025 Feb 7. Expert Rev Endocrinol Metab. 2025. PMID: 39921267 Free article.

Editorial for the Special Issue "Advances in Clinical Diabetes, Obesity, and Metabolic Diseases".

Ohshiro Y, Yagi K, Maeno Y. Ohshiro Y, et al. Medicina (Kaunas). 2025 Mar 26;61(4):595. doi: 10.3390/medicina61040595. Medicina (Kaunas). 2025. PMID: 40282884 Free PMC article.

Comparative Effectiveness and Safety of Oral Versus Subcutaneous Semaglutide in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Karedath J, Nall S, Kaur M, Lokhandwala A, Aqel YH, Maali Abusal A, Wei CR, Allahwala D. Karedath J, et al. Cureus. 2025 Apr 18;17(4):e82497. doi: 10.7759/cureus.82497. eCollection 2025 Apr. Cureus. 2025. PMID: 40385819 Free PMC article. Review.

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 39921267

3 results